Skip to main content

Published locations for Extended-Interval Dosing of Natalizumab Is Associated With Reduced PML Risk

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Extended-Interval Dosing of Natalizumab Is Associated With Reduced PML Risk

User login

  • Reset your password
  • /content/extended-interval-dosing-natalizumab-associated-reduced-pml-risk
  • /neurologyreviews/article/162420/multiple-sclerosis/extended-interval-dosing-natalizumab-associated
  • /multiplesclerosishub/article/162420/multiple-sclerosis/extended-interval-dosing-natalizumab
  • /neurology/article/162420/multiple-sclerosis/extended-interval-dosing-natalizumab-associated-reduced
  • /neurology/msresourcecenter/article/162420/multiple-sclerosis/extended-interval-dosing-natalizumab